IM Cannabis Corp

More Details of IM Cannabis Corp Company

IM Cannabis Corp. is a Canada-based international cannabis company that provides cannabis products to medical patients in Israel and Germany. The Company's ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel. In Germany, the Company operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. It offers four different product lines, leading with the Craft Collection which offers the highest quality Canadian craft cannabis flower. The Company's other product lines include Top-Shelf Collection, Signature Collection and Full Spectrum Extracts. The Company's brands include The WAGNERS, BLKMKT, LOT420, and The PICO collection (minis).

Company Info

Company codeIMCC

Company nameIM Cannabis Corp

IPO dateNov 05, 2019

Founded at1980

CEOMr. Howard Steinberg

Number of employees55

Security typeOrdinary Share

Fiscal year-endNov 05

AddressKibbutz Glil Yam

City

Stock exchangeCanadian Securities Exchange - CSE Listed

CountryIsrael

Postal code4690500

Phone14162564202

Websitehttps://imcannabis.com/

Company codeIMCC

IPO dateNov 05, 2019

Founded at1980

Company Executives

Name

Name/Position

Position

Shareholding

Change

Mr. Oren Shuster

Chairman of the Board, Chief Executive Officer

898.35K

+45.64%

Mr. Shmulik Arbel

Director

54.86K

--

Ms. Einat Zakariya

Independent Director

10.20K

--

Mr. Richard Balla

CEO of Subsidiary

625.00

-28.57%

Ms. Yael Harrosh

Chief Legal and Operations Officer

--

Mr. Howard Steinberg

Chief Executive Officer of Trichome JWC Acquisition Corp and MYM Nutraceuticals Inc

--

Mr. Brian Schinderle

Independent Director

--

Mr. Uri Birenberg

Chief Financial Officer

--

Mr. Michael Ruscetta

Chief Executive Officer of Trichome Financial Corp

--

Mr. Moti Marcus

Independent Director

--

Name

Name/Position

Position

Shareholding

Change

Mr. Oren Shuster

Chairman of the Board, Chief Executive Officer

898.35K

+45.64%

Mr. Shmulik Arbel

Director

54.86K

--

Ms. Einat Zakariya

Independent Director

10.20K

--

Mr. Richard Balla

CEO of Subsidiary

625.00

-28.57%

Ms. Yael Harrosh

Chief Legal and Operations Officer

--

Mr. Howard Steinberg

Chief Executive Officer of Trichome JWC Acquisition Corp and MYM Nutraceuticals Inc

--

Revenue Breakdown

Currency: CADUpdate time: Sun, Apr 6

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q2

FY2023Q1

FY2022

FY2022Q2

FY2022Q1

FY2021

No Data

By RegionCAD

Name

Revenue

Proportion

Israel

38.52M

71.30%

Germany

15.51M

28.70%

Adjustments

0.00

0.00%

By Business

By Region

No Data

Shareholder

Update time: Sat, May 17

Shareholder Statistics

Type

Shareholder Statistics

Shareholder

Proportion

Shuster (Oren)

29.12%

Gabay (Rafael)

16.81%

Lustig (Marc)

5.03%

AdvisorShares Investments, LLC

3.37%

Arbel (Shmulik)

1.78%

Other

43.90%

Shareholder Statistics

Shareholder

Proportion

Shuster (Oren)

29.12%

Gabay (Rafael)

16.81%

Lustig (Marc)

5.03%

AdvisorShares Investments, LLC

3.37%

Arbel (Shmulik)

1.78%

Other

43.90%

Type

Shareholder

Proportion

Individual Investor

53.08%

Investment Advisor

3.78%

Research Firm

0.09%

Other

43.06%

Institutional Shareholding

Update time: Mon, Mar 3

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q1

37

1.48M

47.81%

-157.76K

2024Q4

42

1.47M

47.79%

+350.95K

2024Q3

48

940.41K

38.51%

-167.62K

2024Q2

52

942.46K

38.60%

-171.69K

2024Q1

56

979.54K

40.26%

-121.50K

2023Q4

56

985.22K

44.75%

-141.95K

2023Q3

65

1.02M

46.98%

-107.12K

2023Q2

70

1.00M

46.23%

+11.21K

2023Q1

70

856.29K

40.02%

-3.03K

2022Q4

71

465.21K

38.39%

-77.28K

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

Shuster (Oren)

616.83K

19.99%

+304.69K

+97.61%

Nov 12, 2024

Gabay (Rafael)

389.71K

12.63%

+194.09K

+99.22%

Nov 12, 2024

Lustig (Marc)

155.11K

5.03%

--

Mar 28, 2024

AdvisorShares Investments, LLC

104.08K

3.37%

+615.00

+0.59%

Dec 31, 2024

Arbel (Shmulik)

54.86K

1.78%

+48.35K

+742.69%

Nov 12, 2024

BMO Nesbitt Burns Inc.

12.59K

0.41%

-1.40K

-10.02%

Dec 31, 2024

Zakariya (Einat)

10.20K

0.33%

--

Mar 28, 2024

Desjardins Securities Inc.

3.80K

0.12%

+1.90K

+99.89%

Dec 31, 2024

SBI Securities Co., Ltd.

8.00

0%

+8.00

--

Dec 31, 2024

Balla (Richard)

875.00

0.03%

+381.00

+77.13%

Mar 28, 2024

Related ETFs

Update time: 12 hours ago

Name

Proportion

AdvisorShares Pure Cannabis ETF

0.78%

Amplify Seymour Cannabis ETF

0%

AdvisorShares Pure Cannabis ETF

Proportion0.78%

Amplify Seymour Cannabis ETF

Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Split

Date

Type

Ratio

Jul 09, 2024

Merger

6<1

Jul 09, 2024

Merger

6<1

Jul 09, 2024

Merger

6<1

Jul 09, 2024

Merger

6<1

Nov 15, 2022

Merger

10<1

Nov 15, 2022

Merger

10<1

Date

Type

Ratio

Jul 09, 2024

Merger

6<1

Jul 09, 2024

Merger

6<1

Jul 09, 2024

Merger

6<1

Jul 09, 2024

Merger

6<1

Nov 15, 2022

Merger

10<1

Nov 15, 2022

Merger

10<1

Nov 15, 2022

Merger

10<1

Nov 15, 2022

Merger

10<1

3.480USD

IM Cannabis Corp

3.480

Overview

Company